Decreasing prevalence of neural tube defects in Utah, 1985-2000

Teratology

Volumn 66, Issue SUPPL. 1, 2002, Pages

  Feldkamp, Marcia ^a,b,c   Friedrichs, Michael ^b   Carey, John C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UTAH DEPARTMENT OF HEALTH   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANENCEPHALUS; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; CRANIORACHISCHISIS; ENCEPHALOCELE; EXENCEPHALY; GESTATIONAL AGE; HEAD INJURY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MENINGOCELE; MENINGOMYELOCELE; NEURAL TUBE DEFECT; NEWBORN; PEDIATRICIAN; POPULATION RESEARCH; PREGNANCY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; STILLBIRTH; UNITED STATES;

ABORTION, LEGAL; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; NEURAL TUBE DEFECTS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; UTAH;

EID: 0036391542     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.90006     Document Type: Article

References (28)

1. Abramsky L, Botting B, Chapple J, Stone D. 1999. Has advice on periconceptional folate supplementation reduced neural-tube defects? Lancet 354:998-999.
2. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong L-YC, Gindler J, Hong S-X, Correa A. 1999. Prevention of neural-tube defects with folic acid in China. N Eng J Med 341:1485-1490.
3. Boyle E, Thiessen P, McFadden D, Irwin B, MacLeod P, Chambers K, Van Allen MI. 2001. Neural tube defect (NTD) pregnancy versus birth incidence in B.C.: the true incidence is not declining. J Invest Med 49(1):A36.
4. CDC. 1992. Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41(No. RR-14).
5. Cragen JD, Roberts HE, Edmonds LD, Khoury MJ. 1995. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis - United States, 1985-1994. MMWR 44(SS-4):1-13.
6. Czeizel AR, Dudas I. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
7. DHHS, FDA. 1996. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61(44):8781-8797.
8. Feldkamp M, Marti K, Friedrichs M. 2002. Folic acid awareness, knowledge and consumption among women of childbearing age in Utah, 1998-2000. Am J Med Gen 107:67-69.
9. Governor's Office of Budget and Planning. 2001. Census 2000 Data. State of Utah.
10. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong L-YC. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285(23):2981-2986.
11. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. 1999. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. NEJM 340:1449-1454.
12. Jorde LB, Fineman RM, Martin RA. 1984. Epidemiology of neural tube defects in Utah, 1940-1979. Am J Epi 119(4):487-495.
13. Kennedy D, Chitayat D, Winsor AJT, Silver M, Toi A. 1998. Prenatally diagnosed neural tube defects: Ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. Am J Med Gen 77:317-321.
14. Khoury MJ, Erickson JD, James LM. 1982. Etiologic heterogeneity of neural tube defects: clues from epidemiology. Am J Epi 115:538- 548.
15. Lawrence JM, Petitti DM, Watkins M, Umekubo MA. 1999. Trends in serum folate after food fortification. Lancet 354: September 11, 915-916.
16. Limb CH, Holmes LB. 1994. Anencephaly: Changes in prenatal detection and birth status, 1972 through 1990. Am J Obstet Gynecol 170:1333-1338.
17. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
18. National Birth Defects Prevention Network 2000. 2000. State birth defects surveillance programs directory. Teratology 61(1/2):79.
19. Rosana A, Smithells D, Cacciani L, Botting B, Castilla E, Cornel M, Erickson D, Goujard J, Irgens L, Merlob P, Robert E, Siffel C, Stoll C, Sumiyoshi Y. 1999. Time trend in neural tube defects prevalence in relation to preventive strategies: an international study. J Epidemiol Community Health 53:630-635.
20. SAS Procedures Guide Version 8. Cary, N.C.: SAS Institute, 1999.
21. Smith JL, Schoenwolf GC. 1997. Neurulation: coming to closure. Trends Neurosci 20:510-517.
22. Stevenson R, Allen WP, Pai GS, Best R, Seaver LH, Dean J, Thompson S. 2000. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 106:677-683.
23. Utah Public Health Outcome Measures Report. 2000. Office of the Executive Director, Utah Department of Health, Salt Lake City, Utah. December.
24. Velie EM, Shaw GM. 1996. Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am J Epi 144:473-479.
25. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. 1990. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenatal Diag 10:149-152.
26. Werler MW, Shapiro S, Mitchell AA. 1993. Periconceptional folic acid exposure and risk of concurrent neural tube defects. JAMA 269: 1257-1261.
27. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (in press).
28. Yen IH, Khoury MJ, Erickson JD, James LM, Waters GD, Berry RJ. 1992. The changing epidemiology of neural tube defects - United States, 1968-1989. AJDC 146:857-861.